MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head

Yilin Ye1,2, Jian Wang1, Yunwan Xu1

  • 1Shenzhen Neocura Biotechnology Co. Ltd., Shenzhen, 518055, China.

BMC Bioinformatics
|January 7, 2021
PubMed
Summary

We developed MATHLA, a deep learning framework for predicting human leukocyte antigen (HLA)-peptide binding. This advanced model improves accuracy for HLA-C alleles and longer peptides, crucial for personalized immunotherapy.